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The NANOFOL concept aims at creating nanodevices containing a drug for inflammatory disorder treatment. This paper provides
recommendations for nanosafety based on a measurement campaign which aimed at identifying exposure risks with respect to two
specific phases of the product’s lifecycle, that is, production of the device and itswastemanagement.Thenanoparticle’s presence both
in air and in liquid phase was studied. While no emissions were detected during the production period, many recommendations
have been made, particularly regarding the nanowaste treatment, based on nanosafety guidelines.
1. Introduction
NANOFOL [1] was a European Project supported through
the Seventh Framework Programme for Research and Tech-
nological Development. It aims at improving the treatment of
chronic inflammatory diseases by the development and pro-
duction of nanobiodevices (i.e., nanoliposomes) in nanosafe
conditions. Nanoliposomes are nanosized vesicles made
mainly of phospholipids, able to enclose molecules, and used
as device to facilitate drug transport and penetration into
cells. As a result, a part of this project is devoted to nanosafety
management with different operations which are used to deal
with nanorisk during production and waste management.
Nanosafety is a function of two distinct factors, exposure (of
workers) and hazard (toxicity/ecotoxicity of nanomaterial).
One of the most widely applied standards for exposure
assessment at workplaces is EN 689, 1995 [2]. This standard
enlists the critical points that need to be addressed for a
fair evaluation of these two factors. Table 1 summarizes these
points. In addition, the standard also enlists two preventive
measures to deal for the safety of workers.
As far as the handling and manipulation of the nanosus-
pensions are concerned, there is no such standard available
as per the knowledge of the authors. Moreover, the two
abovementioned factors exposure and hazards are still rather
poorly understood in the context of nanosuspensions [3].
Nanosuspensions are biphasic systems consisting of pure
drug particles (or nanostructured vesicles like liposomes)
dispersed in an aqueous solvent, stabilized by surfactants.
With the ability to improve the stability as well as the
bioavailability of poorly soluble drugs and easiness to prepare,
these nanosuspensions are becoming a vital technology in the
pharmaceutical sector [4]. Hence, it is critical to control the
exposure and hazards associated during their manipulation
for their sustainable development. This has been a subject
of interest of some European Community regulations, for
example, the EC directives 1998 [5] and EP and EC directives
2004 [6]. The main application of these nanosuspensions
is in the production of nanomedicines. The nanostructured
compounds used in nanomedicine are rarely reported as a
main risk [7–9]. Nanomedicine is a relatively new topic in the
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Table 1: Factors to be considered in exposure assessment as enlisted
by NF EN 689, 1995.
Description Points to be addressed
Hazard
(a) Number of sources emitting pollution
(b) Size of the production in relation to production
capacity
(c) Size of each of the sources
(d) Type and location of each source
Probability
of exposure
(a) Dispersion of pollutants by air movement
(b) Proximity to sources/confinement barrier
(c) Time spent in a location
Preventive
measures
(a) Type and efficacy of evacuation and ventilation
systems
(b) Personal working habits
nanorisk framework and the amount of chemical compounds
involved seems to be low compared with industrial products
containing nanomaterials [10].
Elsaesser and Howard [11] reported the need to develop a
regulatory framework based on objective scientific research
which will limit human exposure to safe levels of the
unwanted engineered nanomaterials in the environment.
This approach requires a different framework which balances
the therapeutic benefit against the potential risk to worker
and the environment. In spite of clear improvements of risk
assessment to drive nanodevice conception to safer drug
delivery [12–18], to our knowledge no studies concerning
nanomedicine safety at the workplace have been published.
However nanomedicine recommendations in healthcare
sector [19] or general guideline on nanosafety [20–23] can
also be applied in the context of nanomedicine production
workplace. In case of nanosuspension manipulation, con-
verging recommendations consist consequently to handle
liquid dispersions with adapted personal protective equip-
ment (e.g., nitrile gloves, lab coats, and safety glasses)
under a fume hood. The complementary works that have
studied the nanosuspensions report that the hazards related
to nanosuspension are not only influenced by the particle
nature but also by the dispersant, for example, [24]. Here, the
main recommendation focuses on themanipulated quantities
more than one litre and the nature of the used dispersant
(i.e., flammable, toxic, etc.). In case of nanoparticle pro-
duction under high pressure conditions, a significant risk
of nanoparticle aerosolization has been identified. Lee et al.
[25] and Johnson et al. [26] reported aerosolization during
energetic process using carbon nanotube suspensions. It is
the understanding of the authors that such a behavior of
carbon nanotube suspensions can also be expected in case of
nanoliposome suspensions. Daigle et al. [27] asserted that the
likely exposure route to engineered nanomaterials is through
inhalation, though ingestion or dermal penetration may also
occur [28–30].
The exposure measurement in presence of nanomaterial
use implicates an evaluation of data gathering to estimate
the nanorisk or the critical periods which necessitate a
measurement campaign. These measurements are intended,
whether a nanorisk is identified, to provide evidence for
the nanoparticle presence within the breathing zone of the
workers during the period of nanomaterial use. An appropri-
ate method to perform an exposure measurement campaign
consists of an assessment campaign with a particle counter
and sizer and, if necessary, a complementary campaign of
measurements [31–34].
The present paper assesses the potential of this method in
an industry-like laboratory that produces nanoliposome liq-
uid suspensions. It aims at assessing the exposure to nanopar-
ticles and at providing recommendations with respect to this.
The three steps of this assessment have been
(i) to identify and quantify the sources of nanostructured
particle emissions in the production facility,
(ii) to characterize the emitted aerosol particles in terms
of number concentration,
(iii) to manage the nanoliposome waste in the production
facility by cracking the inherent nanostructure of the
membrane,
(iv) to propose recommendations by means of concrete
measures for the alleviation of the potential exposure
in case of an accident.
A particle counter is used to quantify the number con-
centration of the aerosol particles with an aerosol sampler
to characterize their shape and elemental composition. The
latter also allows for identifying the probable nanoliposome
emissions with certainty as a particle counter cannot differ-
entiate between the process and background related aerosol
particles.
2. Materials and Methods
2.1. Measurement Strategy. Various attempts have been made
in the past to develop a comprehensive assessment strategy
for the measurement campaigns at workplaces or production
sites [34–36]. The design of the assessment strategy relies on
the choice of the exposure measurement instruments which
in turn depends upon the purpose of the measurement (as
outlined by [37, 38]). Besides this, the extensitivity, longevity,
and background aerosols ladening (originating from the
work environment or the process itself) of the assessment
procedure and the production site’s structure or architecture
also play key roles while designing the strategy. In the
present work, the investigated production site is the labo-
ratory of University of Minho (UMINHO) on the Campus
of Azure´m of Guimara˜es (Portugal) which produces the
liquid suspension of the nanoliposomes for manufacturing
nanodrugs which are used for various inflammatory disorder
treatments. As shown in Figure 1, the laboratory is divided in
two parts.The first part is used to store samples and chemical
compounds in a fridge and the second area is used to handle
compounds and produce nanoliposomes. All sorts of product
handling or processing are performed inside the conformity
of a fume hood or directly on the laboratory benches (marked
asA, B, andC). To reduce operators’ risks of exposure, the two
keymeans of action are the air flow andprotective equipment.
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Figure 1: Nanoliposome liquid suspension producing laboratory
floor plan.
The ventilation controls were kept switched off during the
measurement campaign and the air flow was consequently
natural in the laboratory. The protective equipment used
for the operator’s protection is nitrile gloves, safety goggles,
cotton lab coat, and mask.
The different steps during the production process are
presented in Figure 2. The first step consists in weighing
various chemical compounds as dioleoylphosphatidyletha-
nolamine (DOPE), cholesterol (CH), or (N-(carbonylme-
thoxypolyethylene glycol-2000)-1,2-distearoyl-sn-glycero-3-
phosphoethanolamine) DSPE-MPEG using a digital balance
and placing them under the fume hood. In the second
step of handling, these chemical compounds are mixed with
chloroform in definite ratios inside the fume hood 1.
The chloroform is then evaporated inside fume hood
2 during the third step. During fourth step, a lipid film
is prepared on a round bottom flask to prepare for the
nanoliposomes production. This is performed mainly on
the laboratory bench A; see Figure 1. Until this step, no
nanostructured product is present and consequently there is
no risk of exposure to nanoliposomes. The dried lipid film
is treated with phosphate buffered saline (PBS) to prepare
its suspension which is followed by the suspension’s vortex
mixing, to yield multilamellar vesicles (MLVs) the first step
when the nanoliposomes are manufactured. Consequently,
this could be the first moment when their emission might
occur. The extrusion step, through polycarbonate filters, uses
a pressure system, to form large unilamellar vesicles. Follow-
ing extrusion, these nanoliposomes are purified or separated
from the residue by passing the mixture through a SPE col-
umn. Like extrusion, this step could also be a potential source
of nanoliposomes emission and could drive to an inhalation
or dermal exposure risk. Both of these steps are carried out at
A and C places (Figure 1). The DOPE-containing liposomes
formulation is used to stabilize the bilayer form through the
addition of a cleavable lipid derivative of polyethylene glycol
(DSPE-MPEG).This new nanobiodevice has been developed
by UMINHO and tested by other partners and seems to be
the best candidate to be used [3]. Approximately a duration
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Figure 2: A series of steps involved during the production process
of nanoliposome liquid suspensions; the last two steps, that is,
extrusion and purification of these suspensions, are considered to be
the steps during which possible emissions of nanoliposomes might
occur.
of 1 hour 30 minutes is required to produce liquid suspension
of 15mL containing nanoliposomes with a liposomal formu-
lation DOPE/CH/DSPE-MPEG concentration of 11.9mM at
the purification step. The production batch can be repeated 5
times in a day and necessitates only one worker.
Hence, we consider these two stages, that is, extrusion
and purification to be sole potential periods of emission. As
a result, the particle counting and sampling should be done
within this zone only.
Further to the risk of emission to the air, the liquid
suspensions represent an inherent possible accidental source
of nanoparticles.
2.2. Nanoliposome Liquid Suspension Analysis. Before start-
ing the measurement campaign, a characterization of the
final product, that is, nanoliposome liquid suspension, was
carried out. In Figure 3, scattering intensity-weighted particle
size distribution of the nanoliposome liquid suspension,
manufactured by producer, is shown. It was carried out
using Zetasizer Nano ZS (Malvern Instruments) by means of
Dynamic Light Scattering (DLS). A monodispersed distribu-
tion of the nanoliposomes, with a mode just below 100 nm,
can be observed.
For the Transmission Electron Microcopy (TEM, Model
CM12; Philips, Netherlands; shown in Figure 4), 8 𝜇L droplet
from this suspension was deposited on a TEM copper mesh
grid (Model S162; Formvar/Carbon, Quantifoil Micro Tools
GmbH, Germany). The mesh grid was made hydrophilic by
its plasma treatment, 0.1mbar, 45mA, and 3min (Model
K100X, Glow Discharge, Emitech, Quorum Technologies
Ltd., UK), prior to drop deposition. After the deposition, the
grid was then allowed to dry in a closed chamber so that
the aqueous content gets evaporated and the nanoliposomes
rest deposited on the grid. Since many nanoliposomes get
destroyed during drying, a lot of disrupted membranes are
observed in TEM microscopy (examples marked by solid
black arrows in Figure 4). Fortunately, the nanoliposomes
provided by UMINHO are so stable that some of them are
still observable after drying (examples marked by dashed
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Figure 3: Particle size distribution of the liposome liquid suspension
obtained using DLS.
1𝜇m
Figure 4: TEM image of the liposomes obtained after drying a
deposited drop of its liquid suspension on a grid; examples of
liposomes with disrupted membranes are marked with black arrows
and those with stable membrane are marked with white arrows.
white arrows in Figure 4). The size of the nanoliposomes,
in Figure 4, is in a size range of 75 nm to ∼1 𝜇m with small
vesicles in the range of 75 to 150 nm. These observations
are consistent with the previous observations of DLS sizing
(Figure 3). The Energy Dispersive X-ray (EDS) analysis of
the droplet revealed the chemical elements present in the
membrane. An example is shown in Figure 5. Most of the
elements found are ubiquitous like Cl, C, Na, Al, Si, and K.
To be certain of the nature of the sampled aerosol particles
during exposure analysis, the need of a tracer element is
indispensable since this distinguishes the nanoliposomes
from the background particles. For this, the tracer element
(i) should be present inside the vesicular membrane, (ii)
should not to be present in the laboratory environment,
and (iii) should be easily identifiable. The only element
satisfying these criteria is phosphorus (P) which is present in
the phospholipid membranes. Another criterion that can be
taken into account in order to further confirm the release of
aerosolized nanoliposome is its spherical shape asmost of the
background particles are irregularly shaped.
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Figure 5: Elemental composition of one nanoliposome with C, Na,
Cl, K, Al, and P.
2.3. Exposure Analysis. The choice of the exposure measure-
ment device was guided by two factors: (i) portability and
easiness tomanage; (ii) ability tomeasure nanosized particles.
Considering these two factors, the exposure analysis during
the production of the nanoliposomes was carried out using a
Condensation Particle Counter (CPC 3007, TSI Inc.) which
measures particles in the size range from 10 nm to 1 𝜇m. The
sampling time was kept at 1 s with an air flow rate equal to
0.7 L/min. The CPC 3007 was complemented with a Mini
Particle Sampler (MPS; Ecomesure) [39]. It is used for aerosol
particles collection through filtration technique on porous
copper mesh grids (Model S143-3; Quantifoil Micro Tools
GmbH Germany). The use of a sampler is imperative here
because a particle counter is generally insensitive to particle
source or composition and makes it difficult to differentiate
between background and process-related aerosol particles.
Once collected, these particles then can be analyzed through
TEM in order to confirm their nature, that is, background
particles or nanoliposomes.
3. Exposure Assessment Results
The exposure assessment with respect to the production
phase of the product was carried out in three steps:
(a) Preliminary or “naked eye” evaluation of the exposure
on the basis of the points enlisted in Table 1.
(b) Measurement and analysis of the background aerosol
particles with no production activity.
(c) Measurement and analysis of the aerosol particles
during production activity.
Following this investigation, the waste management phase
needed to be considered; see Section 4.
3.1. Data Evaluation Based on EN 689. The points enlisted
in Table 1 were analyzed for the present production site and
observations weremade corresponding to each point. Table 2
summarizes the results.
In Table 2, two main exposure sources are mentioned:
nanoliposomes production and their waste disposal. This
part of the campaign has provided a visual perception of
the workplace (process and work practices) to define the
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Table 2: Responses to the factors considered (field study) [2].
Description Points to be addressed Observations on the production site
Hazard
(a) Number of sources emitting
pollution Three sources: extruder, storage, and garbage
(b) Size of the production and waste
generation in relation to the
production capacity
A daily intensive production (5 batches per day) produces 75mL. If we
consider 260 days/year of production, the maximum total production is
19,500mL/year. The phospholipid concentration in
dioleoylphosphatidylethanolamine (DOPE) is 6.43mM (4.78mg/mL) in the
final product
The waste consists of residues from water based solution which is used to
clean the extruder and tools
(c) Size of each of the sources During extrusion and storage phases, 15mL of nanoliposome suspension isdealt with
(d) Type and location of each source (a) Nanoliposomes production on the three benches A, B, and C,(b) fridge, (c) garbage (Figure 1)
Probability of
exposure
(a) Dispersion of pollutants by air
movement There was neither any measured dispersion nor any ATEX risk identified
(b) Proximity to sources/confinement
barrier Handling without hood
(c) Time passed in a location 10min for handling the nanoliposome liquid suspensions, 60min for theirextrusion, and 30min for their purification
Preventive
measures
(a) Type and efficacy of evacuation and
ventilation systems
Presence of hood for chemical and biological products; no measured
dispersion
(b) Personal working habits In accordance with the chemical/biological riskNo direct account taken yet of nanorisk
Table 3: Statistic data and the observations from the TEM analysis obtained during the three measurement steps.
Mean conc. Min Max Std. Dev. TEM analysis
(#/cm3) (#/cm3) (#/cm3) (#/cm3)
Background 16 764 13 469 29 818 2 188 Oil droplets, soot building debris
Extrusion 11 250 9 189 27 388 822 Oil droplets or soot; no nanoliposomes detected
Purification 38 583 21 440 72 180 7 375 Oil droplets, soot building debris; no nanoliposomes detected
sampling points which could be the potential sources of emis-
sion during production. At the same time, the information
collected during this part has also provided useful inputs,
like details regarding ventilation and personal protection
equipment, to carry out the risk assessment studies. Since
there is high nanoliposome stability after drying, therefore, an
easy and efficientmanagement of their safe disposal is equally
crucial.
3.2. Measurement Results. In Figure 6, the aerosol particles
concentration, obtained using CPC 3007, is shown for the
background particles as well as for the particles emitted
during extrusion and purification steps of the nanoliposomes
production. As already mentioned in Table 2, the duration of
the extrusion and purification steps are 60min and 30min,
respectively. For the background particles, the mean concen-
tration≈17,000 #/cm3 with a standard deviation≈2,200 #/cm3
which proves relatively high fluctuations in the laboratory air
(see Table 3). Towards the end, an increase in the concentra-
tion can be observed (≈30,000 #/cm3). Such fluctuations are
very frequent to be observed at any production site, especially
when the source of ventilation is natural, as in the present
case.
The TEM analysis of the background particles, sampled
at 𝑡 = 10 : 46, reveals the typical nature of any particle
usually found in ambient air, that is, droplets of oil, soot
(Figure 7(a)), and rare cement-type materials (Figure 7(b)).
Theoverview shows amoderately loaded gridwith a common
duration sampling of 6 minutes where drops of oil seem to be
predominant.
Coming back to Figure 6, with respect to the background
particle, no significant change in the number concentration
can be observed during extrusion. The TEM images of the
aerosol particles, sampled during this step, are shown in
Figures 8(a) and 8(b). Like number concentration, there is
no change in their nature too. Same type of oil droplets
(Figure 8(a)) or soot (Figure 8(b)) was observed during
extrusion phase.
In contrast with the extrusion, the purification step does
give rise to an increase in the number concentration (mean
concentration ≈39,000 #/cm3) (Figure 6). This is the highest
mean value obtained during the campaign with maximum
concentration reaching 72,000 #/cm3. Different peaks in the
number concentration curve can be attributed to the open-
ing/closing of the doors in the weighing roomwhich perturbs
the air flow of the laboratory. The absence of nanoliposomes
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Figure 6: (a) Number concentration of the background particles and (b) the ambient airborne particles in the vicinity of the fume hood 1
(breathing zone of the worker) during the extrusion (green color) and purification (black color) of the nanoliposome liquid suspensions.
10𝜇m
(a)
5𝜇m
(b)
Figure 7: (a) Overview of the sampled particles from the background; (b) typical cement-type debris present in the ambient air.
emission during purification is confirmed from the TEM
images of the sampled aerosol particles (Figures 9(a) and
9(b)) which like earlier TEM images also contain soot and
oil droplets.
Hence, in all the activities during production process, the
phosphorus element is never detected in the particles tested
on the grids. Therefore, despite the intensive research and
data collection during both particle counting and aerosols
sampling in the laboratory, it has not been possible to identify
nanoliposomes observed in Figure 4. All the peaks in the
number concentration of the aerosol particles, during either
extrusion or purification, are associatedwith perturbations in
the laboratory’s air flow due to the incidents like the turning
on/off of the fume hood, doors opening/close, and so forth.
4. Nanowaste Management
Nanowaste management has been emphasized recently due
to free or agglomerated nanoparticle release characterization
in smoke or incineration residue [40, 41]. In case of nanopar-
ticles present in sewage due, for example, to feces/urine, one
part of this pollution is detected in the treated effluent [42–
44].
In the framework of this study, the experimentally simu-
lated waste treatment consisted of a dilution by PBS followed
by thermal cracking to manage the nanorisk posed by the
waste. To test the destruction of DOPE formulations of
nanoliposome, we diluted the 20𝜇L sample of the suspension
provided by UMINHO into 10mL of PBS (1/50 v/v) at
ambient temperature, followed by heating at 60∘C for 10
hours. Consequently, there was a complete destruction of the
suspension sample. To illustrate this, Figures 10(a), 10(b), and
10(c) show a shift of the sizemode from 100 nm (Figure 10(a))
to around 1000 nm (Figure 10(c)) which shows a complete
destruction of the nanostructure of the nanoliposome.
5. Recommendations for Nanosafety
No significant emission—compared to the background
noise—was observed during the whole campaign. How-
ever, the possibility of exposure of humans to the emitted
nanostructured material cannot be excluded in case of an
Journal of Nanomaterials 7
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Figure 8: Typical TEM image examples of (a) soot and oil droplets (main compound carbon and iron) and (b) soot (main compound carbon)
reaped during the airborne particles collection while the worker filters the liquid suspensions.
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Figure 9: (a) Typical overview of TEM grid with oil droplets and soot; (b) presence of big cement-type material on the TEM grid during the
purification step.
accident, even though theworkers involved in the production
of nanoliposomes at UMINHO are protected by the use of
nitrile gloves, cotton lab coat, and sometimes safety glasses.
Considering this, the following recommendations are made
here for future producers of devices in order to improve
nanosecurity:
(a) All the operations of production of nanoliposomes
should be carried out in each step under a closed
conformity of a fume hood, particularly the extrusion
and the purification of nanoliposomes activities.
(b) Two nitrile gloves per hand should be worn during all
handling operations.
(c) During transport, a double containment of all materi-
als should be implemented. Plastic bags with air tight
zips can be used to wrap, for example.
(d) All the storages of nanomaterials should be clearly
labeled.
(e) A proposition for a dilution-cracking based proce-
dure for destroying the nanostructure of the nano-
liposomes, thus simplifying the nanowaste manage-
ment, has been made in the present study. The
producers should use such a method to enhance the
nanosafety with respect to their nanowaste.
6. Conclusion
During the campaign at the production site of the nanoli-
posome suspensions, an attentive study of the whole man-
ufacturing process was carried out. Using the NF EN 689
standard, initial evaluations of possible sources of nanolipo-
some emissions were made. The quantification of the aerosol
particles in the vicinity or within the breathing zone of
these sources did not show any significant increase in their
number concentration during various production activities.
Their sampling showed the only presence of oil droplets
or soot which are common particles of the urban aerosols
produced by the human activity (traffic, heating). However,
considering the nanowaste management and unanticipated
accidents at the production site, simple and effective method
and guidelines have also been proposed to ensure nano-
safety.
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